KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Treasury Shares (2016 - 2025)

Bausch Health Companies' Treasury Shares history spans 14 years, with the latest figure at $6.8 million for Q4 2025.

  • For Q4 2025, Treasury Shares rose 9.68% year-over-year to $6.8 million; the TTM value through Dec 2025 reached $6.8 million, up 9.68%, while the annual FY2025 figure was $6.8 million, 9.68% up from the prior year.
  • Treasury Shares for Q4 2025 was $6.8 million at Bausch Health Companies, up from $6.2 million in the prior quarter.
  • Across five years, Treasury Shares topped out at $8.3 million in Q4 2022 and bottomed at $5.3 million in Q4 2023.
  • The 5-year median for Treasury Shares is $6.2 million (2024), against an average of $6.4 million.
  • The largest annual shift saw Treasury Shares skyrocketed 53.7% in 2022 before it plummeted 36.14% in 2023.
  • A 5-year view of Treasury Shares shows it stood at $5.4 million in 2021, then surged by 53.7% to $8.3 million in 2022, then tumbled by 36.14% to $5.3 million in 2023, then grew by 16.98% to $6.2 million in 2024, then grew by 9.68% to $6.8 million in 2025.
  • Per Business Quant, the three most recent readings for BHC's Treasury Shares are $6.8 million (Q4 2025), $6.2 million (Q4 2024), and $5.3 million (Q4 2023).